Other Liabilities, Noncurrent of IDEXX LABORATORIES INC /DE from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
IDEXX LABORATORIES INC /DE quarterly Other Liabilities, Noncurrent in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • IDEXX LABORATORIES INC /DE Other Liabilities, Noncurrent for the quarter ending 30 Sep 2025 was $57,621,000, a 8.4% decline year-over-year.
Source SEC data
View on sec.gov
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $57,621,000 -$5,258,000 -8.4% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $56,788,000 +$3,392,000 +6.4% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $47,731,000 -$18,530,000 -28% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $44,341,000 -$21,185,000 -32% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $62,879,000 +$2,668,000 +4.4% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $53,396,000 -$10,887,000 -17% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $66,261,000 -$4,603,000 -6.5% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $65,526,000 -$2,061,000 -3% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $60,211,000 -$10,742,000 -15% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $64,283,000 -$5,494,000 -7.9% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $70,864,000 -$984,000 -1.4% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $67,587,000 -$3,354,000 -4.7% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $70,953,000 -$2,040,000 -2.8% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $69,777,000 -$15,266,000 -18% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $71,848,000 -$11,701,000 -14% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $70,941,000 -$14,663,000 -17% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $72,993,000 -$6,671,000 -8.4% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $85,043,000 +$836,000 +0.99% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $83,549,000 +$2,256,000 +2.8% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $85,604,000 +$4,440,000 +5.5% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $79,664,000 +$2,586,000 +3.4% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $84,207,000 +$4,855,000 +6.1% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $81,293,000 -$1,271,000 -1.5% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $81,164,000 -$3,662,000 -4.3% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 $77,078,000 -$4,416,000 -5.4% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $79,352,000 -$3,915,000 -4.7% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $82,564,000 -$2,009,000 -2.4% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $84,826,000 -$10,892,000 -11% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 $81,494,000 +$31,911,000 +64% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 $83,267,000 +$34,037,000 +69% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 $84,573,000 +$42,553,000 +101% 31 Mar 2018 10-Q 04 May 2018 2018 Q1
Q4 2017 $95,718,000 +$56,781,000 +146% 31 Dec 2017 10-K 15 Feb 2019 2018 FY
Q3 2017 $49,583,000 +$14,989,000 +43% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 $49,230,000 +$18,902,000 +62% 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 $42,020,000 +$11,659,000 +38% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $38,937,000 +$10,239,000 +36% 31 Dec 2016 10-K 16 Feb 2018 2017 FY
Q3 2016 $34,594,000 +$4,934,000 +17% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 $30,328,000 -$1,006,000 -3.2% 30 Jun 2016 10-Q 02 Aug 2016 2016 Q2
Q1 2016 $30,361,000 -$666,000 -2.1% 31 Mar 2016 10-Q 29 Apr 2016 2016 Q1
Q4 2015 $28,698,000 -$3,665,000 -11% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q3 2015 $29,660,000 -$1,928,000 -6.1% 30 Sep 2015 10-Q 28 Oct 2015 2015 Q3
Q2 2015 $31,334,000 +$670,000 +2.2% 30 Jun 2015 10-Q 30 Jul 2015 2015 Q2
Q1 2015 $31,027,000 -$733,000 -2.3% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 $32,363,000 +$1,148,000 +3.7% 31 Dec 2014 10-K 17 Feb 2016 2015 FY
Q3 2014 $31,588,000 +$2,813,000 +9.8% 30 Sep 2014 10-Q 24 Oct 2014 2014 Q3
Q2 2014 $30,664,000 +$4,904,000 +19% 30 Jun 2014 10-Q 25 Jul 2014 2014 Q2
Q1 2014 $31,760,000 +$6,941,000 +28% 31 Mar 2014 10-Q 25 Apr 2014 2014 Q1
Q4 2013 $31,215,000 +$7,317,000 +31% 31 Dec 2013 10-K 17 Feb 2015 2014 FY
Q3 2013 $28,775,000 +$5,887,000 +26% 30 Sep 2013 10-Q 22 Oct 2013 2013 Q3
Q2 2013 $25,760,000 +$4,500,000 +21% 30 Jun 2013 10-Q 23 Jul 2013 2013 Q2
Q1 2013 $24,819,000 +$4,798,000 +24% 31 Mar 2013 10-Q 23 Apr 2013 2013 Q1
Q4 2012 $23,898,000 +$6,168,000 +35% 31 Dec 2012 10-K 18 Feb 2014 2013 FY
Q3 2012 $22,888,000 +$7,609,000 +50% 30 Sep 2012 10-Q 19 Oct 2012 2012 Q3
Q2 2012 $21,260,000 +$8,306,000 +64% 30 Jun 2012 10-Q 20 Jul 2012 2012 Q2
Q1 2012 $20,021,000 +$7,737,000 +63% 31 Mar 2012 10-Q 20 Apr 2012 2012 Q1
Q4 2011 $17,730,000 +$6,685,000 +61% 31 Dec 2011 10-K 19 Feb 2013 2012 FY
Q3 2011 $15,279,000 +$2,853,000 +23% 30 Sep 2011 10-Q 21 Oct 2011 2011 Q3
Q2 2011 $12,954,000 +$1,232,000 +11% 30 Jun 2011 10-Q 22 Jul 2011 2011 Q2
Q1 2011 $12,284,000 31 Mar 2011 10-Q 21 Apr 2011 2011 Q1
Q4 2010 $11,045,000 31 Dec 2010 10-K 17 Feb 2012 2011 FY
Q3 2010 $12,426,000 30 Sep 2010 10-Q 22 Oct 2010 2010 Q3
Q2 2010 $11,722,000 30 Jun 2010 10-Q 23 Jul 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.